Breast cancer study aims to find best Pre-Surgery therapy

NCT ID NCT05621564

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at how different treatments given before surgery (like chemo, radiation, or hormone therapy) affect breast cancer patients' response and long-term survival. Researchers will compare results based on the type of treatment and patient characteristics. The goal is to learn which pre-operative approach works best for different people.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
pre-operative therapy (chemotherapy, radiation, endocrine therapy, targeted therapy, or other anti-tumor drugs)
What this could lead to
If successful, this could help doctors choose the best pre-operative treatment for each breast cancer patient, potentially improving survival and response rates.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may vary by patient group and may not apply to all.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Renji Hospital, School of Medicine, Shanghai Jiaotong University

    RECRUITING

    Shanghai, 200127, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.